buformin has been researched along with Neoplasms in 4 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metabolic reprogramming in cancer is considered to be one of the most important hallmarks to drive proliferation, angiogenesis, and invasion." | 1.91 | Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study. ( Arredondo-Espinoza, EU; Balderas-Renteria, I; Carranza-Rosales, P; Espinosa-Rodriguez, BA; Mendez-Lopez, LF; Ramirez-Cabrera, MA; Ramirez-Estrada, K; Treviño-Almaguer, D, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espinosa-Rodriguez, BA | 1 |
| Treviño-Almaguer, D | 1 |
| Carranza-Rosales, P | 1 |
| Ramirez-Cabrera, MA | 1 |
| Ramirez-Estrada, K | 1 |
| Arredondo-Espinoza, EU | 1 |
| Mendez-Lopez, LF | 1 |
| Balderas-Renteria, I | 1 |
| Lu, M | 1 |
| Xing, H | 1 |
| Cheng, L | 1 |
| Liu, H | 1 |
| Lang, L | 1 |
| Yang, T | 1 |
| Zhao, X | 1 |
| Xu, H | 1 |
| Ding, P | 1 |
| Anisimov, VN | 1 |
| Semenchenko, AV | 1 |
| Yashin, AI | 1 |
| Dil'man, VM | 1 |
| Bershteĭn, LM | 1 |
| Tsyrlina, EV | 1 |
| Bobrov, IuF | 1 |
| Kovaleva, IG | 1 |
1 review available for buformin and Neoplasms
| Article | Year |
|---|---|
A dual-functional buformin-mimicking poly(amido amine) for efficient and safe gene delivery.
Topics: AMP-Activated Protein Kinases; Animals; Buformin; Cell Line, Tumor; Gene Transfer Techniques; Geneti | 2020 |
3 other studies available for buformin and Neoplasms
| Article | Year |
|---|---|
Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study.
Topics: AMP-Activated Protein Kinases; Antimalarials; Biguanides; Buformin; Creatine; Humans; Metformin; Mol | 2023 |
Insulin and longevity: antidiabetic biguanides as geroprotectors.
Topics: Aging; Animals; Buformin; Female; Humans; Hypoglycemic Agents; Insulin; Longevity; Mice; Neoplasms; | 2003 |
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
Topics: Adrenal Cortex Hormones; Aged; Biguanides; Blood Glucose; Body Weight; Breast Neoplasms; Buformin; C | 1975 |